Juravinski Hospital and Cancer Centre Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2018
NCT03402945
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Juravinski Cancer Centre at Hamilton Health Sciences Centre, Hamilton, ON Canada | Juravinski Hospital and Cancer Centre